supplementNot FDA-approvedOTC supplementSold in the US as an unregulated dietary supplement marketed for inflammation and swelling, not an FDA-approved drugThe systematic review noted overall evidence quality as low, with most positive trials being small and industry-sponsored
SerrapeptaseBenefits, Dosage & Interactions
Serrapeptase, also known as serratiopeptidase, is a proteolytic enzyme derived from the Enterobacteriaceae bacterium, Serratia marcescens. This bacterium was originally found in the intestine of the silkworm, Bombyx mori, where the enzyme plays a role in dissolving the silkworm's cocoon.
How much Serrapeptase do people take?
Cited randomized trials used oral serratiopeptidase (serrapeptase) at 10–30 mg per day (roughly 10,000–30,000 units), divided into two or three doses. Route reported: Oral enteric-coated tablets in both cited randomized trials. Frequency reported: Two to three times daily in the cited trials. These are amounts documented in the cited studies and labels for Serrapeptase — they are reported for reference, not a recommendation. Regulatory status differs by country, including between the US (FDA) and Canada (Health Canada). Confirm any amount with a licensed clinician before you take it.
See the full reported protocol and its sourcesResearched by DoseRoutine Research TeamReviewed for accuracy by Nicholas Alexander, RSE, SO, PMPLast updated Educational reference only — not medical advice. Always confirm dosing and safety decisions with a licensed clinician.
Evidence: Mixed — 3 human studies have been published and have not shown a consistent effect.
Evidence strengthMixed · 2/4
PreclinicalStrong human evidence
3 human studies have been published and have not shown a consistent effect.
Plasma half-life
Not applicable
Typical timing
in the morning
Food rule
on an empty stomach
Default unit
mg
What published protocols report
Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.
Reported for Serrapeptase in the cited sources. Published ranges are not dosing advice.
References & evidence
Documents the Serrapeptase entry is written from. Each number matches an inline marker above.
- [1]Serratiopeptidase: a systematic review of the existing evidenceBhagat S, Agarwal M, Roy V · International Journal of Surgery · 2013 · Peer-reviewed · PMID 23380245
- [2]The treatment of breast engorgement with Serrapeptase (Danzen): a randomised double-blind controlled trialKee WH, Tan SL, Lee V, Salmon YM · Singapore Medical Journal · 1989 · Peer-reviewed · PMID 2688125
- [3]Efficacy of serratiopeptidase after impacted third molar surgery: a randomized controlled clinical trialTamimi Z, Alsousi B, Nassani MZ, et al. · BMC Oral Health · 2021 · Peer-reviewed · PMID 33653320
References & Evidence
Sources on this page that document Serrapeptase dosing, timing and safety.
- [1]National Center for Biotechnology Information View source
Educational information only — not medical advice. Dose ranges vary by person, indication and prescriber.
What is Serrapeptase studied for?
What is Serrapeptase?Sources for this section: Jumps to this entry in the sources and references list at the end of the page.
Serrapeptase, also known as serratiopeptidase, is a proteolytic enzyme derived from the *Enterobacteriaceae* bacterium, *Serratia marcescens*. This bacterium was originally found in the intestine of the silkworm, *Bombyx mori*, where the enzyme plays a role in dissolving the silkworm's cocoon. Serrapeptase has been investigated for its potential anti-inflammatory and pain-reducing properties, primarily due to its ability to break down proteins. It is available as a dietary supplement and has been studied for various conditions, including post-operative swelling, sinusitis, and carpal tunnel syndrome, though the extent of its efficacy and safety in all contexts is still under active research (PubChem). As an enterically-coated enzyme, it is designed to bypass stomach acid and be absorbed in the intestine, allowing it to exert systemic effects.
What does the research say about Serrapeptase?
Tap a section to expand.
The primary mechanism of action for serrapeptase involves its proteolytic activity, meaning it breaks down proteins. When absorbed into the bloodstream, serrapeptase is believed to target non-living tissues, such as fibrin, bradykinin, and other inflammatory mediators, without harming living tissue (Examine.com). By hydrolyzing these protein-based inflammatory compounds, serrapeptase may help reduce local inflammation and associated pain. It is also thought to help clear dead or damaged tissue, facilitating better circulation and nutrient delivery to affected areas. Some research suggests it might also reduce the viscosity of mucus and other secretions, which could be beneficial in conditions involving respiratory congestion (PubChem). This enzyme also exhibits fibrinolytic activity, meaning it can break down fibrin, a protein involved in blood clotting and scar tissue formation, potentially contributing to its anti-inflammatory effects and aiding in the resolution of swelling.
Source for this section: Sources for How does Serrapeptase work?: Jumps to this entry in the sources and references list at the end of the page.
Serrapeptase has been explored for several potential benefits, primarily related to its anti-inflammatory and pain-reducing properties. Early studies, particularly from Japan and Europe, investigated its use for post-operative and post-traumatic swelling, aiming to accelerate recovery and reduce discomfort.
* **Reduction of Swelling and Inflammation:** Serrapeptase is often studied for its ability to reduce swelling following surgery or injury. It is thought to break down inflammatory exudates and facilitate their removal (Examine.com).
* **Pain Relief:** By reducing inflammation, serrapeptase may indirectly alleviate pain associated with various conditions, including musculoskeletal issues and chronic inflammatory states.
* **Sinusitis and Respiratory Issues:** Some research suggests serrapeptase may help in conditions like sinusitis by thinning mucus secretions, potentially improving sinus drainage and reducing congestion (PubChem). This mucolytic effect is also explored for other respiratory conditions.
* **Carpal Tunnel Syndrome:** Preliminary studies have investigated serrapeptase for carpal tunnel syndrome, suggesting it might help reduce inflammation and pressure on the median nerve, though more robust evidence is needed.
* **Atherosclerosis:** There is some experimental interest in serrapeptase's potential to break down plaques in arteries due to its fibrinolytic activity, but this application is highly speculative and not supported by clinical evidence for human use (Examine.com). This proposed benefit is considered theoretical and requires extensive further research before any clinical relevance can be established.
While these potential benefits are areas of ongoing research, the highest quality evidence often pertains to its use in reducing post-operative swelling. Individual responses to serrapeptase can vary, and its use should always be discussed with a healthcare professional.
The evidence for serrapeptase's efficacy varies across different conditions. Clinical studies have explored its use, with some indicating positive outcomes, particularly in reducing inflammation and swelling.
* **Post-operative Swelling:** Several randomized controlled trials have investigated serrapeptase for reducing post-operative swelling and pain, particularly in oral surgery and ear, nose, and throat (ENT) procedures. A review of these studies, including some published in peer-reviewed journals, suggests that serrapeptase may have a moderate effect in reducing swelling and pain after minor surgical procedures (Examine.com, Cochrane reviews have looked at related enzymes). However, the quality and size of some earlier studies have been noted as limitations, with calls for larger, more rigorous trials.
* **Sinusitis:** Some smaller studies and clinical observations have suggested that serrapeptase could be beneficial in chronic sinusitis by altering the viscosity of mucus. These findings are often from observational studies or small trials and require confirmation through larger, double-blind, placebo-controlled studies (PubChem).
* **Carpal Tunnel Syndrome (CTS):** limited preliminary evidence, including some case series, has explored serrapeptase for CTS, suggesting it might offer some relief from symptoms. However, this evidence is not considered conclusive, and larger, well-designed clinical trials are necessary to establish its role in CTS management (Examine.com).
* **Atherosclerosis and Arterial Plaque:** Claims regarding serrapeptase's ability to dissolve arterial plaque lack substantial clinical human evidence. This proposed application is largely theoretical, based on its fibrinolytic activity in experimental settings, and has not been validated in human clinical trials (Examine.com).
Overall, while serrapeptase shows promise as a systemic enzyme with anti-inflammatory properties, particularly in post-operative recovery, more high-quality, large-scale clinical trials are needed to fully establish its efficacy and define its role in various therapeutic contexts. The existing body of evidence, while suggestive in some areas, does not uniformly meet the highest standards of evidence-based medicine across all proposed uses.
Serrapeptase is generally considered well-tolerated by many individuals, but like all supplements, it can cause side effects. The most commonly reported side effects are gastrointestinal in nature.
* **Gastrointestinal Upset:** This can include nausea, vomiting, stomach upset, and diarrhea. These symptoms are usually mild and may resolve with continued use or by taking the supplement with food, though serrapeptase is often recommended on an empty stomach for optimal absorption.
* **Skin Rash:** Some individuals have reported developing a skin rash after taking serrapeptase.
* **Anorexia:** In rare instances, appetite loss has been noted.
* **Bleeding Risk:** Due to its fibrinolytic properties, serrapeptase theoretically carries a risk of increasing bleeding or bruising, especially at higher doses or in individuals with pre-existing bleeding disorders or those taking anticoagulant medications (Examine.com, PubChem).
If any side effects occur, particularly severe gastrointestinal distress, allergic reactions, or unusual bleeding, discontinue use and consult a healthcare professional. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
While serrapeptase is available as a supplement, certain situations warrant caution or complete avoidance. It is important to heed these warnings to ensure safe use.
* **Bleeding Disorders:** Individuals with bleeding disorders, such as hemophilia, or those with a history of easy bruising should exercise extreme caution due to serrapeptase's potential to increase bleeding risk.
* **Surgery:** Due to its potential effect on blood clotting, serrapeptase should be discontinued at least two weeks before any scheduled surgery, including dental procedures, and should not be resumed until approved by the surgeon (Mayo Clinic recommendations for similar compounds).
* **Immunosuppressed Individuals:** There is limited information on the effects of serrapeptase in immunocompromised individuals. Exercise caution and consult a healthcare provider.
* **Children and Pregnant/Breastfeeding Individuals:** There is insufficient reliable evidence regarding the safety of serrapeptase during pregnancy, breastfeeding, or in children. Therefore, its use is generally not recommended in these populations. Individuals in these groups should always consult a clinician before considering any supplement.
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Serrapeptase is contraindicated in certain individuals due to significant health risks.
* **Active Bleeding Conditions:** Individuals with any active bleeding, such as gastrointestinal ulcers, recent stroke with hemorrhage, or other acute bleeding conditions, should not use serrapeptase. Its fibrinolytic action could worsen bleeding.
* **Known Allergy/Hypersensitivity:** Anyone with a known allergy or hypersensitivity to serrapeptase or any of its components should avoid its use.
* **Severe Liver or Kidney Disease:** Individuals with severe liver or kidney impairment should exercise extreme caution, as the metabolism and excretion of serrapeptase may be affected, potentially leading to increased blood levels and side effects. Generally, use is not advised without explicit medical guidance.
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Serrapeptase can interact with certain medications and other supplements, potentially increasing the risk of adverse effects. It is crucial to be aware of these interactions.
* **Anticoagulants (Blood Thinners):** Serrapeptase has fibrinolytic properties and can theoretically increase the effect of anticoagulant medications such as warfarin (Coumadin), heparin, clopidogrel (Plavix), and dabigatran (Pradaxa). This combination significantly increases the risk of bleeding and bruising (DrugBank, MedlinePlus).
* **Antiplatelet Drugs:** Similar to anticoagulants, serrapeptase may enhance the effects of antiplatelet drugs (e.g., aspirin, dipyridamole), leading to an increased risk of bleeding.
* **NSAIDS (Non-Steroidal Anti-Inflammatory Drugs):** While not a direct interaction, combining serrapeptase with NSAIDs (e.g., ibuprofen, naproxen) could theoretically lead to an increased cumulative risk of gastrointestinal upset or bleeding, especially for individuals prone to these issues.
* **Herbal Supplements with Anticoagulant/Antiplatelet Effects:** Other supplements known to thin the blood, such as garlic, ginger, ginkgo biloba, and high-dose vitamin E, might also interact with serrapeptase, compounding the risk of bleeding (NIH ODS).
Always disclose all medications, supplements, and herbal remedies you are taking to your healthcare provider to assess potential interactions before starting serrapeptase. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Serrapeptase is commonly studied at various doses, often taken multiple times a day. Individual needs vary — talk to a licensed clinician. It is typically recommended to be taken on an empty stomach, which means at least 30-60 minutes before a meal or at least two hours after a meal. This timing helps ensure that the enterically-coated enzyme passes through the stomach quickly, avoiding degradation by stomach acid, and reaches the small intestine for optimal absorption. Taking it with food could potentially reduce its effectiveness by delaying its passage or causing it to be broken down by digestive enzymes. The typical timing for serrapeptase is in the morning, often before breakfast, and then again later in the day, again on an empty stomach.
Source for this section: Sources for When should you take Serrapeptase?: Jumps to this entry in the sources and references list at the end of the page.
Put it into practice
Reading about Serrapeptase is the first step — DoseRoutine helps you act on it. These free tools turn what you just learned into a routine.
What interacts with Serrapeptase?
| Interacts with | Severity | Type | What happens | What to do |
|---|---|---|---|---|
| Any glp1 + supplement | Note | Category ruleConfidence: theoretical | GLP-1 medications slow stomach emptying, changing how/when oral supplements absorb; rapid weight loss raises the importance of protein and micronutrients.Source pending | Time oral supplements when nausea is lowest; prioritize protein and micronutrients; discuss with your provider. |
| Any supplement + medication | Note | Category ruleConfidence: theoretical | Some supplements change how the body processes medications (absorption, liver enzymes, or additive effects).Source pending | Specific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist. |
| Warfarin | Caution | Compound pairConfidence: theoretical | Additive antiplatelet/antithrombotic effect increases bleeding risk.Source pending | Discuss with prescribing clinician; monitor for bruising, prolonged bleeding, and dose adjustments. |
| Any + | Caution | Category ruleConfidence: theoretical | Additive antiplatelet/antithrombotic effect increases bleeding risk.Source pending | Discuss with prescribing clinician; monitor for bruising, prolonged bleeding, and dose adjustments. |
| Apixaban | Caution | Compound pairConfidence: theoretical | Additive antiplatelet/antithrombotic effect increases bleeding risk.Source pending | Discuss with prescribing clinician; monitor for bruising, prolonged bleeding, and dose adjustments. |
| Rivaroxaban | Caution | Compound pairConfidence: theoretical | Additive antiplatelet/antithrombotic effect increases bleeding risk.Source pending | Discuss with prescribing clinician; monitor for bruising, prolonged bleeding, and dose adjustments. |
| Dabigatran | Caution | Compound pairConfidence: theoretical | Additive antiplatelet/antithrombotic effect increases bleeding risk.Source pending | Discuss with prescribing clinician; monitor for bruising, prolonged bleeding, and dose adjustments. |
| Clopidogrel | Caution | Compound pairConfidence: theoretical | Additive antiplatelet/antithrombotic effect increases bleeding risk.Source pending | Discuss with prescribing clinician; monitor for bruising, prolonged bleeding, and dose adjustments. |
Frequently asked questions about Serrapeptase
Serrapeptase is primarily studied for its potential anti-inflammatory and pain-reducing effects. It is often investigated for reducing swelling after surgery or injury, potentially assisting with chronic inflammatory conditions, and in some cases, thinning mucus in respiratory conditions like sinusitis (PubChem).
Serrapeptase functions as a proteolytic enzyme, meaning it targets and breaks down specific proteins. It is believed to hydrolyze non-living protein particles associated with inflammation, such as fibrin and bradykinin, helping to reduce swelling and pain without harming living tissue (Examine.com).
Serrapeptase is generally considered well-tolerated by many people when used appropriately. However, it can cause gastrointestinal side effects and carries a theoretical risk of increased bleeding due to its blood-thinning properties. It's contraindicated in individuals with active bleeding or those on anticoagulant medications. Always consult a healthcare professional before starting serrapeptase (MedlinePlus).
Yes, Serrapeptase can interact with certain medications, most notably anticoagulant (blood-thinning) drugs like warfarin and antiplatelet medications (e.g., aspirin), significantly increasing the risk of bleeding. It may also interact with other herbal supplements that thin the blood. Always discuss your full medication and supplement list with your doctor (DrugBank).
Serrapeptase is typically recommended to be taken on an empty stomach – at least 30-60 minutes before a meal or two hours after a meal – to optimize its absorption and minimize degradation by stomach acid. The typical timing is in the morning.
Serrapeptase is typically taken in the morning. Published protocols usually have it taken on an empty stomach. Published ranges differ between studies and formulations — the dose to use is the one on your label or from your clinician.
There is no single answer for Serrapeptase plus TRT. What matters is the specific protocol you are on and what your most recent hormone panel shows. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions
Pairing Serrapeptase with peptides has to be assessed one peptide at a time, because GLP-1 agonists, secretagogues, healing peptides and melanocortins do not share an interaction profile. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.
Published frequency for Serrapeptase varies by protocol and formulation, so the label or prescription is what sets it. It is typically taken in the morning. Most protocols have it taken on an empty stomach. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps
The effect of a missed dose of Serrapeptase depends on the protocol and formulation you are on. Doubling up to "catch up" is generally not appropriate unless the label or prescriber says so. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.
For Serrapeptase the useful record is the dose, the time it was actually taken, and what else was taken in the same window. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.
Cited randomized trials used oral serratiopeptidase (serrapeptase) at 10–30 mg per day (roughly 10,000–30,000 units), divided into two or three doses. Route reported: Oral enteric-coated tablets in both cited randomized trials. Frequency reported: Two to three times daily in the cited trials. These are amounts documented in the cited studies and labels for Serrapeptase — they are reported for reference, not a recommendation. Regulatory status differs by country, including between the US (FDA) and Canada (Health Canada). Confirm any amount with a licensed clinician before you take it.
Which studies looked at Serrapeptase?
Peer-reviewed research indexed in PubMed. Each entry links to the original record.
- 1.Effect of the proteolytic enzyme serrapeptase on swelling, pain and trismus after surgical extraction of mandibular third molars(opens PubMed in a new tab)Int J Oral Maxillofac Surg · 2008 · PMID 18272344 · https://pubmed.ncbi.nlm.nih.gov/18272344/
- 2.Effect of the proteolytic enzyme serrapeptase in patients with chronic airway disease(opens PubMed in a new tab)Respirology · 2003 · PMID 12911824 · https://pubmed.ncbi.nlm.nih.gov/12911824/
Sources cited on this page
Specific documents referenced by the numbered markers above. Each number matches the marker in the text.
- PubChem CID 171666295(opens in a new tab)National Center for Biotechnology Information · pubchem.ncbi.nlm.nih.gov/compound/171666295
Verify at
Publisher search links for Serrapeptase. These are places to check the information — they are not citations, so they are not numbered.
- Examine.com(publisher search, opens in a new tab)Examine.com · publisher search
- DrugBank(publisher search, opens in a new tab)DrugBank Online · publisher search
- Mayo Clinic(publisher search, opens in a new tab)Mayo Clinic · publisher search
- NIH Office of Dietary Supplements(publisher search, opens in a new tab)National Institutes of Health · publisher search
- Cochrane Library(publisher search, opens in a new tab)Cochrane · publisher search
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
- DailyMed labeling archive(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
- Wikipedia entry(publisher search, opens in a new tab)Wikipedia · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on Serrapeptase?
Plain-text summary, safe to quote verbatim:
Serrapeptase, also known as serratiopeptidase, is a proteolytic enzyme derived from the Enterobacteriaceae bacterium, Serratia marcescens. This bacterium was originally found in the intestine of the silkworm, Bombyx mori, where the enzyme plays a role in dissolving the silkworm's cocoon.
Source: DoseRoutine — https://doseroutine.com/library/serrapeptase
Serrapeptase cheat sheet
DoseRoutine cheat sheet · Supplement
Serrapeptase
Serrapeptase, also known as serratiopeptidase, is a proteolytic enzyme derived from the Enterobacteriaceae bacterium, Serratia marcescens. This bacterium was originally found in the intestine of the silkworm, Bombyx mori, where the enzyme plays a role in dissolving the silkworm's cocoon.
Evidence
Mixed
3 human studies have been published and have not shown a consistent effect.
Studied range
Cited randomized trials used oral serratiopeptidase (serrapeptase) at 10–30 mg per day (roughly 10,000–30,000 units), divided into two or three doses
Route
Oral enteric-coated tablets in both cited randomized trials
Frequency studied
Two to three times daily in the cited trials
Timing
in the morning
With food
on an empty stomach
Not FDA-approvedOTC supplementSold in the US as an unregulated dietary supplement marketed for inflammation and swelling, not an FDA-approved drugThe systematic review noted overall evidence quality as low, with most positive trials being small and industry-sponsoredRecovery
Key references
Studied ranges, not dosing advice. Not medical advice — talk to a clinician. doseroutine.com/library/serrapeptase
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). Serrapeptase — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/serrapeptase
What compounds are similar to Serrapeptase?
Others in the supplement category or studied for the same goals.
Which goals is Serrapeptase used for?
Other compounds studied for the same benefits as Serrapeptase.
Continue exploring
See every compound DoseRoutine catalogs for these goals.